Literature DB >> 21243010

Surgery for asymptomatic degenerative aortic and mitral valve disease.

Prashant Vaishnava1, Valentin Fuster, Martin Goldman, Robert O Bonow.   

Abstract

Degenerative valvular heart disease, the most common form of valve disease in the Western world, can lead to aortic stenosis (AS) or mitral regurgitation (MR). In current guidelines for the management of patients with degenerative valvular disease, surgical intervention is recommended at the onset of symptoms or in the presence of left ventricular systolic impairment. Whether surgery is appropriate for asymptomatic patients remains a controversial issue. We argue the case for early pre-emptive intervention in selected, asymptomatic individuals with AS or MR, drawing on contemporary perioperative data, predictors of disease progression, and studies of the natural history of degenerative valvular heart disease.

Entities:  

Mesh:

Year:  2011        PMID: 21243010     DOI: 10.1038/nrcardio.2010.203

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  30 in total

1.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

2.  Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation.

Authors:  James S Gammie; Sean M O'Brien; Bartley P Griffith; T Bruce Ferguson; Eric D Peterson
Journal:  Circulation       Date:  2007-02-05       Impact factor: 29.690

3.  Early surgery is recommended for mitral regurgitation.

Authors:  Maurice Enriquez-Sarano; Thoralf M Sundt
Journal:  Circulation       Date:  2010-02-16       Impact factor: 29.690

Review 4.  Valvular heart disease: diagnosis and management.

Authors:  Kameswari Maganti; Vera H Rigolin; Maurice Enriquez Sarano; Robert O Bonow
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

5.  Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up.

Authors:  Patricia A Pellikka; Maurice E Sarano; Rick A Nishimura; Joseph F Malouf; Kent R Bailey; Christopher G Scott; Marion E Barnes; A Jamil Tajik
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

6.  Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.

Authors:  Francesco Grigioni; Jean-François Avierinos; Lieng H Ling; Christopher G Scott; Kent R Bailey; A Jamil Tajik; Robert L Frye; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

7.  Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients.

Authors:  Tirone E David; Joan Ivanov; Susan Armstrong; Harry Rakowski
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

8.  Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation.

Authors:  M Enriquez-Sarano; A J Tajik; H V Schaff; T A Orszulak; K R Bailey; R L Frye
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

9.  Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis.

Authors:  M Enriquez-Sarano; H V Schaff; T A Orszulak; A J Tajik; K R Bailey; R L Frye
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

10.  Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation.

Authors:  Rodolfo Pizarro; Oscar O Bazzino; Pablo F Oberti; Mariano Falconi; Federico Achilli; Anibal Arias; Juan G Krauss; Arturo M Cagide
Journal:  J Am Coll Cardiol       Date:  2009-09-15       Impact factor: 24.094

View more
  8 in total

1.  Impact of New York Heart Association classification, advanced age and patient-prosthesis mismatch on outcomes in aortic valve replacement surgery.

Authors:  Alex Zapolanski; Andrew W C Mak; Giovanni Ferrari; Christopher Johnson; Richard E Shaw; Mariano E Brizzio; Jason S Sperling; Juan B Grau
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-04

2.  Is comorbidity equivalent to symptoms in asymptomatic AS?

Authors:  Daniyar Gilmanov; Annamaria Mazzone; Sergio Berti; Mattia Glauber
Journal:  Nat Rev Cardiol       Date:  2011-11-25       Impact factor: 32.419

Review 3.  Current management of calcific aortic stenosis.

Authors:  Brian R Lindman; Robert O Bonow; Catherine M Otto
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

4.  Quantitative evaluation of change in coexistent mitral regurgitation after aortic valve replacement.

Authors:  David J Kaczorowski; John W Macarthur; Jessica Howard; Dale Kobrin; Alex Fairman; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-11       Impact factor: 5.209

Review 5.  Timing of aortic valve intervention in pediatric chronic aortic insufficiency.

Authors:  Justin T Tretter; Alan Langsner
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

6.  Trends in aortic valve replacement for elderly patients in the United States, 1999-2011.

Authors:  José Augusto Barreto-Filho; Yun Wang; John A Dodson; Mayur M Desai; Lissa Sugeng; Arnar Geirsson; Harlan M Krumholz
Journal:  JAMA       Date:  2013-11-20       Impact factor: 56.272

Review 7.  The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes.

Authors:  Francesco Nicolini; Andrea Agostinelli; Antonella Vezzani; Tullio Manca; Filippo Benassi; Alberto Molardi; Tiziano Gherli
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

8.  Mutations in DCHS1 cause mitral valve prolapse.

Authors:  Ronen Durst; Kimberly Sauls; David S Peal; Annemarieke deVlaming; Katelynn Toomer; Maire Leyne; Monica Salani; Michael E Talkowski; Harrison Brand; Maëlle Perrocheau; Charles Simpson; Christopher Jett; Matthew R Stone; Florie Charles; Colby Chiang; Stacey N Lynch; Nabila Bouatia-Naji; Francesca N Delling; Lisa A Freed; Christophe Tribouilloy; Thierry Le Tourneau; Hervé LeMarec; Leticia Fernandez-Friera; Jorge Solis; Daniel Trujillano; Stephan Ossowski; Xavier Estivill; Christian Dina; Patrick Bruneval; Adrian Chester; Jean-Jacques Schott; Kenneth D Irvine; Yaopan Mao; Andy Wessels; Tahirali Motiwala; Michel Puceat; Yoshikazu Tsukasaki; Donald R Menick; Harinath Kasiganesan; Xingju Nie; Ann-Marie Broome; Katherine Williams; Amanda Johnson; Roger R Markwald; Xavier Jeunemaitre; Albert Hagege; Robert A Levine; David J Milan; Russell A Norris; Susan A Slaugenhaupt
Journal:  Nature       Date:  2015-08-10       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.